Language selection

Search

2014-06-06 - Female - 32 Years old

900102057

Adverse reaction report number 900102057
Latest AER version number 1
Market authorization holder AER number CA201402708
Initial received date 2014-06-06
Latest received date 2014-07-17
Age 32 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Not recovered/not resolved
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral30 Milligram Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Date modified: